# DIFFERIN
> **NDA021753** · New Drug Application · Sponsor: GALDERMA LABS LP · Approved 2007-06-19
## Drug
- **FDA Application Number:** NDA021753
- **Application type:** New Drug Application
- **Brand name:** DIFFERIN
- **Generic name:** ADAPALENE
- **Active ingredients:** ADAPALENE
- **Dosage form:** GEL
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** GALDERMA LABS LP
- **Manufacturer:** Mayne Pharma Commercial LLC.
- **First approval:** 2007-06-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021753)
---
*AI Analytics · CC0 1.0*